Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects

Colorectal cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

(2020) Zhilin Zou et al.   Cell and Bioscience

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

(2019) Stephen P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Invasion and metastasis: the elusive hallmark of cancer

(2019) Tomer Meirson et al.   ONCOGENE

European cancer mortality predictions for the year 2018 with focus on colorectal cancer

(2018) M Malvezzi et al.   ANNALS OF ONCOLOGY

Insights into the effects of the endocannabinoid system in cancer: a review

(2018) Ana Isabel Fraguas-Sánchez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis

(2017) Ester Pagano et al.   PHARMACOLOGICAL RESEARCH

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

(2016) Stefania Petrosino et al.   BRITISH JOURNAL OF PHARMACOLOGY

TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway

(2016) Guohe Song et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway

(2016) Giovanni Sarnelli et al.   PHYTOTHERAPY RESEARCH

Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent

(2014) Francesca Borrelli et al.   BRITISH JOURNAL OF PHARMACOLOGY

Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1receptors and TRPV1 channels

(2014) Raffaele Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation

(2013) Giuseppe Esposito et al.   GUT

The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action

(2012) Laurie Hamtiaux et al.   BMC CANCER

Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1

(2012) Kristin Stock et al.   NATURE MEDICINE

Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism

(2011) Laurie Hamtiaux et al.   PLoS One

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Inflammation and Colon Cancer

(2010) Janoš Terzić et al.   GASTROENTEROLOGY